Kodama Tatsuya, Kouzaki Yuji, Kawano Shuichi, Obinata Hirofumi, Taniguchi Hiroaki, Sasaki Hisashi, Ota Shinichiro, Kawana Akihiko, Tamura Kaku
Division of Pulmonary Medicine, Department of Internal Medicine, Self-Defense Forces Central Hospital, 1-2-24 Ikejiri, Setagaya, Tokyo 154-8532, Japan.
Division of Infectious Diseases and Pulmonary Medicine, Department of Internal Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan.
J Infect Chemother. 2020 Nov;26(11):1220-1223. doi: 10.1016/j.jiac.2020.07.003. Epub 2020 Jul 17.
Coronavirus disease 2019 (COVID-19) is spreading worldwide and poses an imminent threat to public health. We encountered 2 cases of COVID-19 with progression resulting in severe respiratory failure and improvement without any specific treatment. To examine the course of infection, we performed reverse-transcription (RT) polymerase chain reaction assay with serum specimens, and serum SARS-CoV-2 RNA was detected in both cases when body temperature increased and respiratory status deteriorated. We, then examined, retrospectively and prospectively, the clinical course during hospitalization by performing serial examinations of serum SARS-CoV-2 RNA status. The findings from our cases suggest that not only is detection of viremia useful as a predictive marker of severity, but also serial serum SARS-CoV-2 RNA results can be helpful for predicting the clinical course.
2019冠状病毒病(COVID-19)正在全球范围内传播,对公众健康构成紧迫威胁。我们遇到了2例COVID-19患者,病情进展导致严重呼吸衰竭,但未经任何特殊治疗而好转。为了研究感染过程,我们对血清标本进行了逆转录(RT)聚合酶链反应检测,在两例患者体温升高且呼吸状况恶化时均检测到血清严重急性呼吸综合征冠状病毒2(SARS-CoV-2)RNA。然后,我们通过对血清SARS-CoV-2 RNA状态进行系列检查,回顾性和前瞻性地研究了住院期间的临床过程。我们病例的研究结果表明,不仅病毒血症的检测作为严重程度的预测标志物有用,而且系列血清SARS-CoV-2 RNA结果有助于预测临床过程。